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Gold nanoparticles (AuNPs) are a fascinating class of nanomaterial that can be used for a wide range of biomedical
applications, including bio-imaging, lateral flow assays, environmental detection and purification, data storage, drug
delivery, biomarkers, catalysis, chemical sensors, and DNA detection. Biological synthesis of nanoparticles appears to
be simple, cost-effective, non-toxic, and easy to use for controlling size, shape, and stability, which is unlike the
chemically synthesized nanoparticles. The aim of this study was to synthesize homogeneous AuNPs using
pharmaceutically important Ganoderma spp. We developed a simple, non-toxic, and green method for
water-soluble AuNP synthesis by treating gold (III) chloride trihydrate (HAuCl4) with a hot aqueous extract of the
Ganoderma spp. mycelia. The formation of biologically synthesized AuNPs (bio-AuNPs) was characterized by
ultraviolet (UV)-visible absorption spectroscopy, X-ray diffraction (XRD), Fourier transform infrared spectroscopy
(FTIR), energy dispersive X-ray (EDX), dynamic light scattering (DLS), and transmission electron microscopy (TEM).
Furthermore, the biocompatibility of as-prepared AuNPs was evaluated using a series of assays, such as cell viability,
lactate dehydrogenase leakage, and reactive oxygen species generation (ROS) in human breast cancer cells
(MDA-MB-231). The color change of the solution from yellow to reddish pink and strong surface plasmon resonance
were observed at 520 nm using UV-visible spectroscopy, and that indicated the formation of AuNPs. DLS analysis
revealed the size distribution of AuNPs in liquid solution, and the average size of AuNPs was 20 nm. The size
and morphology of AuNPs were investigated using TEM. The biocompatibility effect of as-prepared AuNPs was
investigated in MDA-MB-231 breast cancer cells by using various concentrations of AuNPs (10 to 100 μM) for 24 h.
Our findings suggest that AuNPs are non-cytotoxic and biocompatible. To the best of our knowledge, this is the
first report to describe the synthesis of monodispersed, biocompatible, and soluble AuNPs with an average size
of 20 nm using Ganoderma spp. This study opens up new possibilities of using an inexpensive and non-toxic
mushroom extract as a reducing and stabilizing agent for the synthesis of size-controlled, large-scale, biocompatible,
and monodispersed AuNPs, which may have future diagnostic and therapeutic applications.
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In recent years, gold nanoparticles (AuNPs) have been
of great research interest because of their unique proper-
ties, such as size- and shape-dependent optoelectronic,
physiochemical, and biological properties as well as vari-
ous potential therapeutic applications. AuNPs possess dis-
tinct physical and chemical properties that make them
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reproduction in any medium, provided the origsensors [1-3]. First, AuNPs can be synthesized using a
simple method and made highly stable. Second, they pos-
sess unique optoelectronic properties. Third, they provide
high surface-to-volume ratios with excellent biocom-
patibility when using appropriate ligands [1]. Fourth,
these AuNP properties can be readily tuned by varying
their size and shape as well as the surrounding chemical
environment [3].
Because of their stability, oxidation resistance, and bio-
compatibility, AuNPs have a wide range of potential appli-
cations, such as in electronics and photonics, catalysis,
information storage, chemical sensing and imaging, drugis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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AuNPs is an important process to enhance versatility in
defining and controlling the shape [5]. Thus, new meth-
odologies are essential for designing shape-controlled
synthesis of AuNPs [6-8].
Several synthetic chemical methods have been adopted
for AuNP synthesis, including physical methods, such as
attrition and pyrolysis, which were previously utilized for
the synthesis of metallic nanoparticles [9]. Alternatively,
chemical methods are the most widely and traditionally
used methods and incorporate various reducing agents,
such as hydrazine [9] and sodium borohydride [10]. How-
ever, many of these methods can be cumbersome and in-
volve the use of toxic chemicals, high temperatures, and
pressures and, most importantly, can cause the particles
to become unstable or aggregate upon interaction with
biological media or biomolecules [11]. At the same time,
these approaches produce multi-shaped nanoparticles that
require purification by differential centrifugation, and con-
sequently have a low yield [12,13]. Therefore, there is a
constant need for new methodologies to produce shape-
controlled synthesis of AuNPs.
Recently, several labs have been interested in develop-
ing methodologies for synthesis of nanomaterials using a
green chemistry approach, which is an alternate approach
to biosynthesizing nanomaterials that relies on natural or-
ganisms for the reduction of metal ions into stable nano-
crystals [14-21]. Biological methods are supposed to yield
novel and complex structural entities, unlike those
obtained using conventional techniques [14,15,22]. A
number of microbial species have been used for synthe-
sis of metal nanoparticles but without much success in
achieving shape control. The shape-controlled microbial
synthesis of nanostructures is an exciting new area with
considerable potential for development. Recently, Das
et al. reported the synthesis of single-crystalline AuNPs
[19] and different nanostructures from HAuCl4 using
Rhizopus oryzae [5].
Biological methods exhibit size and shape control over
a diverse array of materials, and they also facilitate mass
production, high yield, and reproducibility [23,24]. Biosyn-
thesis of AuNPs and silver nanoparticles (AgNPs) have
been reported in different prokaryotic organisms, includ-
ing Bacillus licheniformis [20], Brevibacterium casei [21],
Bacillus subtilis [25], Escherichia coli [26], Lactobacillus
[27], Pseudomonas aeruginosa [28], and Rhodopseudomo-
nas capsulate [29]. Several researchers exploited fungi as
reducing agents for AgNP synthesis, including fungi such
as Verticillium [14], Fusarium oxysporum [16], Aspergillus
fumigatus [30], Penicillium fellutanum [31], Volvariella
volvacea [32], Pleurotus florida [33], Candida [34], Gano-
derma lucidum [35], and Neurospora crassa [36].
Among nanoparticles, AuNPs have immense potential
for cancer diagnosis and therapy. Conjugation of AuNPsto ligands on cancer cells allows molecular imaging and
detection of cancer [37]. Further, AuNPs have potential
applications in electronics, catalysis, biological sensors,
cancer diagnostics, therapeutics, nanomedicine, and envir-
onmental work, because they have several merits, such as
the fact that they are easy to synthesize, cost effective, and
non-toxic, and they have easy functionalization, optical
properties, facile surface chemistry, and biocompatibility
[37,38]. Moreover, biological processes could provide sig-
nificant yield and are free from downstream processing;
therefore, many researchers are interested in synthesizing
nanoparticles with green manufacturing technology that
uses bacteria, fungi, plants, and plant products.
In most studies, either AuNPs or AgNPs were synthe-
sized using bacteria. Many fungi have not been explored,
including those mentioned above, and only a few fungi
have been investigated for AuNP and AgNP synthesis.
Among fungi that have not been tested, Ganoderma spp.
have long been used as medicinal mushrooms in Asia,
and they have an array of pharmacological properties, in-
cluding immunomodulatory activity and pharmacological
properties [39]. Ganoderma spp. have several advantages:
They have large quantities of viable mycelia, they are cost-
effective, there is easy downstream processing, and they
are non-pathogenic. Moreover, the synthesized AuNPs are
highly soluble in water. Therefore, the aim of this study
was to investigate the possible use of Ganoderma spp. as
green producers for AuNP synthesis and to further evalu-
ate the biocompatibility effect of as-prepared AuNPs in
human breast cancer cells (MDA-MB-231).Methods
Reagents
Gold (III) chloride trihydrate was purchased from Sigma
(St. Louis, MO, USA). Penicillin-streptomycin solution,
trypsin-EDTA solution, Dulbecco's modified Eagle's
medium (DMEM/F-12), and 1% antibiotic-antimycotic
solution were obtained from Life Technologies GIBCO
(Grand Island, NY, USA). All the other chemicals and
reagents were purchased from Sigma (St. Louis, MO,
USA), unless otherwise specified.Culturing and maintenance of Ganoderma spp.
The culture of Ganoderma spp. was collected from a
tropical forest near Pollachi, Tamilnadu, India. Culturing
and maintenance were conducted as described in previ-
ous studies, with suitable modifications [40,41]. Briefly,
the mycelia were cultured on potato dextrose agar (PDA)
and incubated at 28°C ± 2°C for 7 days. The mycelia were
then transferred to glucose yeast malt peptone broth
(GYMP). The inoculated medium was incubated at 28°C ±
2°C and agitated at 150 rpm for 10 days. After incubation,
the mycelia were harvested, washed with distilled water,
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to use.
Preparation of mycelia hot aqueous extract
The preparation of mushroom extract was carried out
according to a method described in previous studies
[40,41], with suitable modifications. In brief, the freeze-
dried mycelia were soaked in distilled water at a ratio of
1:20 and double boiled for 45 min, left to cool, and filtered
through Whatman filter paper No. 4. The hot aqueous ex-
tract was then freeze-dried at −70°C ± 2°C for 48 h and
stored at 4°C in airtight containers. The freeze-dried hot
aqueous extract of the mycelia was used as the reducing
and stabilizing agent for AuNP synthesis.
Synthesis of AuNPs
Synthesis of AuNPs was carried out according to the
method described earlier [21]. In a typical reaction, 1 mg/
mL of freeze-dried hot aqueous mushroom mycelia extract
was mixed with an aqueous solution of 1 mM HAuCl4 so-
lution and kept at room temperature for 24 h. Synthesis
was observed using ultraviolet (UV)-visible spectroscopy.
The color change observed was from pale yellow to pur-
ple. To compare the efficiency of biologically prepared
AuNPs, we used citrate-mediated synthesis of AuNPs
(chem-AuNPs) from Sigma.
Characterization of AuNPs
Characterization of synthesized AuNPs was carried out
according to previously described methods [20]. The
nanoparticles were primarily characterized by UV-visible
spectroscopy, which has proven to be a very useful tech-
nique for nanoparticle analysis [26]. UV-visible (UV-vis)
spectra were obtained using a WPA (Biowave II, Biochrom,
Cambridge, UK). Dispersion particle size was measured by
Zetasizer Nano ZS90 (Malvern Instruments Limited,
Malvern, UK).
The synthesized AuNPs were freeze dried, powdered,
and used for X-ray diffraction (XRD) analysis. The spectra
were evaluated using an X-ray diffractometer (PHILIPS
X'Pert-MPD diffractometer, Amsterdam, the Netherlands)
and Cu-Kα radiation (1.5405 Å) over an angular range of
10° to 80° at 40 kV and 30 mA. The dried powder was di-
luted with potassium bromide at a the ratio of 1:100, and
the results were recorded using the Fourier transform
infrared spectroscopy (FTIR; PerkinElmer Inc., Walham,
MA, USA) and spectrum GX spectrometry within the
range of 500 to 4,000 cm−1.
Transmission electron microscopy (TEM, JEM-1200EX,
JEOL Ltd., Tokyo, Japan) was used to determine the size
and morphology of AuNPs. AuNPs were prepared by
dropping a small amount of aqueous dispersion on copper
grids, which were dried and then examined in the TEM.
Further, the presence of Au metals in the sample wasanalyzed by energy dispersive X-ray analysis (EDX) com-
bined with a field emission SEM.
Cell culture
MDA-MB-231 human breast cancer cells were kindly
provided by Kyung Jin Lee, Institute for Life Sciences,
ASAN Medical Center, University of Ulsan College of
Medicine. MDA-MB-231 breast cancer cell lines were
grown adherently and maintained in DMEM containing
10% fetal calf serum (FCS) and 1% antibiotic solution
containing penicillin and streptomycin at 37°C under 5%
CO2. All the experiments were performed in six-well
plates, unless stated otherwise. Cells were seeded onto
plates at a density of 1 × 106 cells per well and incubated
for 24 h prior to the experiments. The cells were washed
with phosphate buffered saline (PBS, pH 7.4) and incu-
bated in fresh medium containing different concentra-
tions of AuNPs dissolved in water.
Cell viability assay
In order to evaluate the biocompatibility of the as-prepared
AuNPs, we carried out cell viability assay in breast cancer
cells (MDA-MB-231) by using MTT reagents. In addition,
to compare the biocompatibility effect of bio-AuNPs, we
used chemical-mediated synthesis of chem-AuNPs as a
positive control. Cell viability was measured using the 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
dye reduction assay performed to determine the cytotoxic
effect of the AuNPs at various concentrations. Briefly,
the cells were plated onto 96-well flat-bottom culture
plates with various concentrations of AuNPs (0 to100
μM). All the cultures were incubated for 24 h at 37°C in
a humidified incubator. After 24 h of incubation (37°C,
5% CO2 in a humid atmosphere), 10 μL of MTT (5 mg/
mL in PBS) was added to each well, and the plate was
incubated for another 4 h at 37°C. The resulting formazan
was dissolved in 100 μL of DMSO with gentle shaking at
37°C, and the absorbance was measured at 595 nm by
using an ELISA reader (Spectra MAX; Molecular Devices,
Sunnyvale, CA, USA). The results are shown as the mean
of three independent experiments.
Membrane integrity
Cell membrane integrity of MDA-MB-231 cells was evalu-
ated by determining the activity of lactate dehydrogenase
(LDH) leaking out of the cell, according to the manufactur-
er's instructions (in vitro toxicology assay kit, TOX7,
Sigma, USA). The LDH assay is based on the release of the
cytosolic enzyme LDH from cells with damaged cellular
membranes. Thus, in cell culture, AuNPs induced cytotox-
icity and were quantitatively analyzed by measuring the
activity of LDH in the supernatant. Briefly, cells were ex-
posed to various concentrations of AuNPs for 24 h, and
then 100 μL per well of each cell-free supernatant was
Figure 1 Synthesis and characterization of AuNPs. The figure
inset shows tubes containing samples of the Ganoderma spp. extract
(1); 1 mM aqueous HAuCl4 (2); extract after incubation with HAuCl4
(3). The absorption spectrum of AuNPs exhibited a strong broad
peak at 520 nm, and this band was assigned to surface plasmon
resonance of the particles.
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100 μL of LDH-assay reaction mixture was added to each
well. After 3-h incubation under standard conditions, the
optical density of the generated color was determined at a
wavelength of 490 nm using a Microplate Reader.
Determination of ROS
Intracellular reactive oxygen species (ROS) were measured
based on the intracellular peroxide-dependent oxidation
of 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA,
Molecular Probes, Eugene, OR, USA) to form the fluores-
cent compound 2′,7′-dichlorofluorescein (DCF), as previ-
ously described. Cells were seeded onto 24-well plates at a
density of 5 × 104 cells per well and cultured for 24 h.
After washing twice with PBS, fresh medium containing
100 μM of AuNPs, 1 mM H2O2, or AgNPs (5 μg/mL) was
added, and the cells were incubated for 24 h. For the con-
trol, cells were added to 20 μM of DCFH-DA and incuba-
tion continued for 30 min at 37°C. The cells were rinsed
with PBS, 2 mL of PBS was added to each well, and fluor-
escence intensity was determined with a spectrofluorome-
ter (Gemini EM) with excitation at 485 nm and emission
at 530 nm. For the control, had antioxidant N-acetyl-L-
cystein (NAC, 5 mM) was added to the cells grown in 24-
well plates (for 24 h) for 1 h prior to exposure to AuNPs,
1 mM H2O2, or AgNPs (5 μg/mL) for 24 h. We then
added 20 μM of DCFH-DA, and the cells were incubated
for 30 min at 37°C before measuring DCF fluorescence
changes as described.
Results and discussion
Extracellular synthesis of AuNPs
Primary characterization of the ability of Ganoderma
spp. mushroom extract for AuNP synthesis was analyzed.
The Figure 1 inset shows tubes with the Ganoderma spp.
mycelia extract [1], HAuCl4 [2], and extract after reaction
with HAuCl4 ions for 24 h [3]. As expected, the color
changed from pale yellow to deep purple in the presence
of the extract, which indicates AuNP formation and is evi-
dence of synthesis.
Further, to determine if there was AuNP synthesis, the
biosynthesis of nanoparticle reactions was monitored by
UV-vis spectroscopy. UV-vis absorption spectroscopy is
the most widely used technique for characterizing the
optical properties and electronic structure of nanoparti-
cles, because the absorption bands are related to the
diameter and different aspect ratios of metal nanoparti-
cles, including size and shape [42]. As shown in Figure 1,
the spectra of AuNP synthesis showed a gradual increase
in the surface plasmon resonance (SPR) excitation peak
centered at 520 nm, which is characteristic of AuNPs
[11,43]. This further indicates that the mushroom extract
could be useful as a reducing agent for AuNP synthesis.
Control reactions in the absence of mushroom extractexhibited no change in color or absorbance at 520 nm,
clearly indicating that the protein and polysaccharides
found in the extract are responsible for biosynthesis of
AuNPs.
Previous studies demonstrated that metal biotransform-
ation might involve a complex of either capping proteins/
peptides and reductases, quinines, cytochromes, phyto-
chelatins, or electron shuttles that are known to reduce
various metals and metal oxides [11,43-46]. Das et al. [47]
proposed possible mechanisms of AuNP synthesis in Rhi-
zopus oryzae. The first mechanism is binding of Au (III)
on the cell wall through electrostatic interaction followed
by reduction to AuNPs by proteins/enzymes present on
the cell wall, and the second is diffusion or transportation
of Au (III) into the cytoplasm and protein/enzymatic re-
duction to form AuNPs. Taken together, these results
indicate that AuNP synthesis could be facilitated by the
presence of proteins in the extract.
XRD analysis of AuNPs
The crystalline nature of as-prepared AuNPs was con-
firmed using XRD. The XRD spectrum shows two pre-
dominant peaks that agree with Bragg's reflection of
AuNPs reported in a previous study, which used extracel-
lular and intracellular culture supernatant of Aspergillus
fumigatus and Aspergillus flavus [48]. The diffraction
peaks, which appeared at 31.6°C and 45.4°C corresponded
to the (111) and (200) planes, respectively (Figure 2). No
extra peak was observed in the diffraction peaks, which in-
dicates that the as-prepared AuNPs were highly purified
without any contamination.
Figure 2 X-ray diffraction spectra of AuNPs.
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peaks at 2θ angle: 38.22, 44.42, 64.71, and 77.62 with
Bragg reflections corresponding to (111), (200), (220),
and (311) in biomass-associated AuNPs. Alternatively,
only a single prominent peak was observed at 2θ angle:
38.22 with a Bragg reflection corresponding to (111) in
extracellular AuNPs. Our present findings are consistent
with earlier studies that used biological methods to
synthesize AuNPs using plant extracts [49-51], yeast
[16], and bacteria [20].
FTIR analysis
The AuNPs synthesized by Ganoderma spp. mushroom
extract were subjected to FTIR analysis to identify the
biomolecules involved in stabilizing the nanoparticles in
solution [51]. The AuNPs synthesized by mushroom ex-
tract yielded strong bands at 602, 1096, 1201, 1388, and
1636 cm−1 (Figure 3). These bands correspond to theFigure 3 FTIR spectra of AuNPs.amide I, II, and III bands of polypeptides/proteins, and
are consistent with previous reports [51,52]. As suggested
by Sastry et al., the polypeptides found in the mushroom
extracts served as capping agents in AuNPs, particularly
glutathione, which is known to be produced by yeast
cells [53].
It is well known that proteins can bind to AuNPs ei-
ther through free amine groups or cysteine residues in
the proteins [54]; therefore, stabilization of the AuNPs
by surface-bound proteins is a possibility in the case of
AuNPs synthesized by Ganoderma spp. Additionally, the
bands at 1,636 cm−1 can be assigned to the vibrational
modes of C=C double bonds of these molecules. The large
peak between 1,500 and 1,700 cm−1 falls in the region of
C=O stretching frequency, and the bands at 3,492 cm−1
correspond to carbonyl and hydroxyl functional groups in
alcohols and phenol derivatives [11,16,55]. The FTIR re-
sults show that the surface capping of AuNPs synthesized
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Moreover, our results are consistent with those reported
earlier for biosynthesized nanoparticles [11,16,50,51,55].
AuNP synthesis by the Ganoderma spp. extract was
confirmed using EDS and spectra, as represented in
Figure 4. The EDS profile shows a strong gold signal
along with weak oxygen and carbon peaks, which may
have originated from the biomolecules of the mushroom
extract that bound to the AuNP surfaces.Particle size analysis
Further characterization was carried out to determine
the particle size distributions using dynamic light scat-
tering (DLS) technique, which reveals the average hydro-
dynamic diameter of particles in a liquid suspension.
These particle sizes are well within the range reported
for photoluminescence of AuNPs [15]. Figure 5 shows
the DLS analysis of mushroom extract-mediated synthe-
sis of AuNPs; the average size (20 nm) is within the ex-
pected range of particle sizes between 15 to 30 nm and
is very similar to the size that was observed in TEM
(20 nm). However, for particle sizes larger than 25 nm,
the bandwidth increases with the increase in particle size
[42], and nanoparticles such as gold and silver have also
been shown to exhibit size-dependent optical proper-
ties. Husseiny et al. [28] observed the absorption spectra
of AuNPs using three different strains of P. aeruginosa
ATCC 90271, P. aeruginosa, and P. aeruginosa, and the
maximum absorption peaks observed were 543, 540,
and 531 nm corresponding to particle sizes of 30 ± 10,
25 ± 15, and 15 ± 5 nm, respectively.
In our results, we found that the absorption peak is at
520 nm, which corresponds to a particle size of 20 nm.
Moreover, our results are consistent with the absorption
spectra and particle size analysis data obtained for chem-
ically prepared AuNPs that have a characteristic band at
524 nm, corresponding to a 20-nm particle size. ToFigure 4 EDX spectra of AuNPs.confirm the particular size and shape, synthesized AuNPs
were further analyzed using TEM.
TEM analysis
TEM micrographs of the AuNPs revealed distinct, uni-
form molecules that were spherical in shape and well sep-
arated from each other (Figure 6). The average particle
size was estimated from counting more than 200 particles
from TEM images, and the average size of homogeneous,
spherical AuNPs was 20 nm. Interestingly, the AuNPs
synthesized by Ganoderma spp. are spherical and smaller
than those synthesized by other fungi, such as Colletotri-
chum spp. [51] and edible mushrooms [32]; most import-
antly, the prepared nanoparticles were homogeneous and
spherical in shape.
Homogeneous nanoparticles with specific shapes are
important for applications in biological and chemical
sensing as well as for optical, medical, and electronic
devices because the optical properties of AuNPs are
dependent on the size and shape [56]. Several studies
have reported synthesis of various size AuNPs using
different fungi. Fusarium oxysporum produced spherical
and triangular morphologies of particles with a size range
of 20 to 40 nm [15]. Honary et al. [57] reported that Peni-
cillium aurantiogriseum, Penicillium citrinum, and Peni-
cillium waksmanii synthesized AuNPs that were fairly
uniform with spherical shapes and had average diameters
of 153.3, 172, and 160.1 nm, respectively. Alternatively,
the fungi Aspergillus fumigates [30] and Neurospora
crassa [36] produced average AuNP sizes of 25 and
32 nm, respectively.
Effect of AuNPs on cell viability
The use of nontoxic and biocompatible nanoparticles with
capping materials is an important aspect of biomedical ap-
plications. Consequently, the cytotoxic effects and future
health problems caused by nanoparticles must be consid-
ered in the engineering of such materials. It is essential to
Figure 5 Size distribution analysis of AuNPs by DLS. The particle-size distribution revealed that the average particle size was 20 nm.
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compatible, because biomedical applications of any
nanomaterial involves intentional exposure to nanopar-
ticles. Therefore, understanding the properties of nano-
particles and their effects on the human body are
crucial before they are clinically applied [58].
The biocompatibility of both AuNPs was assessed by a
proliferation assay, using mitochondrial functional activ-
ity as an indicator of cell viability. The cells were treated
with different concentrations of both bio- and chem-
AuNPs for 24 h, using the cell viability assay. We found
that cells treated with bio-AuNPs showed no toxic effect,
even at higher concentrations (Figure 7A), which suggests
that as-prepared AuNPs possess biocompatible properties,
whereas the chem-AuNPs showed a slight decrease of cell
viability at higher concentrations. However, the results are
not statistically different from those of the controls. It was
also confirmed by incubating AuNPs with medium only
and checking the absorption at a wavelength used for
MTT assay that the presence of all tested AuNPs did not
interfere with the assay.Figure 6 Size and shape analysis of AuNPs by TEM. Several fields were
AuNPs (A). Selected area of electron diffraction pattern (B).Shukla et al. [59] suggested that AuNPs are not cyto-
toxic, reduce the production of reactive oxygen and
nitrite species, and do not stimulate secretion of proin-
flammatory cytokines, such as TNF-alpha and IL1-beta,
making them suitable candidates for nanomedicine.
Using a human leukaemia cell line, gold nanospheres of
different sizes (4, 12, and 18 nm in diameter) and cap-
ping agents were found to be nontoxic based on the
MTT assay [60]. Similarly, Arnida et al. [61] found that
plain spherical AuNPs and PEGylated spheres and rods
did not interfere with the proliferation of PC-3 cells
when cells were exposed to as high as 1.5 nM of AuNPs
for a period of over two population doubling times
(88 h). Plain spherical particles that were 50 and 90 nm
in diameter slightly stimulated the proliferation of PC-3
cells. Parab et al. [58] investigated the biocompatibility
effect of sodium hexametaphosphate (HMP)-stabilized
AuNPs (Au-HMPs) in tumor and fibroblast cells. Synthe-
sized Au-HMP nanoparticles and their surface-modified
counterparts revealed non-cytotoxic properties in tested
cells and showed biocompatibility.photographed and used to determine the size and morphology of
Figure 7 The effect of AuNPs on cell viability of MDA-MB-231 human breast cancer cells. MDA-MB-231 human breast cancer cells were
treated with bio-AuNPs (A) or chem-AuNPs (B) at various concentrations from 0 to 100 μM/mL for 24 h, and cell viability was determined by the
MTT method. The results are expressed as the mean ± SD of three separate experiments, each of which contained three replicates. Treated groups
were not statistically different from the control group based on the Student's t test.
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based drug delivery system (DDS) (Au-DOX) containing
doxorubicin (DOX). Administration of this DDS to breast
cancer cells (MCF-7 and MDA-MB-231) showed signifi-
cant inhibition of breast cancer cell proliferation com-
pared with pristine doxorubicin. The viability of the
bovine retinal pigment epithelial cells was not affected
with an AuNP concentration of up to 300 nM, and in-
creasing the concentrations above 300 nM resulted in
significant cell death [62]. AuNPs have anti-oxidative
and anti-hyperglycemic activities in streptozotocin-
induced diabetic mice by balancing or inhibiting ROS
generation in hyperglycemic conditions by scavenging
free radicals and leading to increased anti-oxidant defense
enzymes in mice.Figure 8 The effect of AuNPs on membrane integrity of cells. MDA-M
chem-AuNPs (B) at various concentrations from 0 to 100 μM/mL for 24 h,
The results are expressed as the mean ± SD of three separate experiments,
statistically different from the control group based on the Student's t test (Effect of AuNPs on LDH leakage
To determine whether AuNPs have an effect on LDH
leakage, which is a vital marker of cell death, the cells
were treated with various concentrations of bio- and
chem-AuNPs (0 to 100 μM) for 24 h. It is interesting to
observe that, when treated with both AuNP solutions,
there was no change in the leakage of LDH level for up to
24 h in comparison with the untreated control (Figure 8).
The LDH and cell viability data are consistent and show
no reduction of cell proliferation at higher gold concentra-
tions after 24 h.
Pan et al. [63] found that 1.4-nm gold nanospheres trig-
gered necrosis and mitochondrial damage and induced
oxidative stress in endothelial and epithelial cells. In
contrast, they found no evidence of cellular damage forB-231 human breast cancer cells were treated with bio-AuNPs (A) or
and LDH leakage was estimated as described in the ‘Methods’ section.
each of which contained three replicates. Treated groups were not
p > 0.05).
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[63], and these results also suggest that the toxicity of
AuNPs depends on size. Interestingly, citrate-capped
AuNPs (13 nm in diameter) were found to be toxic to a
human carcinoma lung cell line but not to a human liver
carcinoma cell line at the same dosage [64].
Uboldi et al. [65] reported that, after 24 to 48 h of
exposure, AuNPs induced a mild LDH release in the hu-
man ATII-like cell line A549, independent of the pres-
ence or absence of surface contaminants. Additionally,
after 72 h of exposure to AuNPs, there was a dose-
dependent release of LDH in the supernatant, and the
amount of LDH released was significantly higher com-
pared with shorter exposure times. Zhang et al. [66] re-
ported that chloroplast-mediated synthesis of AuNPs
retained up to 85% better viability in both GES-1 and
MGC-803 cells, even up to 150 μg/mL after 36 h of
treatment. Freese et al. [67] studied the effect of AuNPs
on the amount of LDH released into the supernatant, and
they suggest that up to 100 μM of AuNPs did not induce
cytotoxicity in human dermal microvascular endothelial
cells (HDMECs) and human cardiac microvascular endo-
thelial cells (hCMECs). Altogether, our findings suggest
that the biologically derived AuNPs with an average size
of 20 nm are biocompatible.
ROS generation
ROS, which are a specific type of oxygen-containing
reactive molecule, play important roles in various cel-
lular processes and are known to be essential for basal
cell proliferation [68]. Higher concentrations of ROS
lead to cell death [69,70]. Several studies suggested thatFigure 9 The effect of AuNPs in ROS generation. Relative fluorescence
485 nm and emission at 530 nm. The results are expressed as the mean ± S
replicates. Treated groups with bio- and chem-AuNPs were not statistically
(p > 0.05). H2O2- and AgNP-treated groups were statistically different from tnanoparticle-mediated cytotoxicity is associated with ROS
production.
In this case, we further examined the effect of AuNPs on
oxidative stress utilizing the fluorescent dye H2DCFDA,
which does not exhibit enhanced fluorescence in the pres-
ence of AuNPs. Results from exposure of MDA-MB-231
to 100 μM of AuNP solution indicate that there are no
noticeable increases of ROS generation at the treated
concentrations. The results indicate that both bio- and
chem-AuNPs are largely ineffective at inducing ROS
generation in MDA-MB-231 cells, whereas H2O2- and
AgNP-treated groups showed remarkable increase in
ROS generation (Figure 9).
Chuang et al. [71] extensively studied the exposure of
three different-sized AuNPs in human gastric carcinoma
(AGS) and human lung adenocarcinoma epithelial (A549)
cells. Their results suggest that significant increases of ROS
generation occur with certain concentrations of AuNPs in
AGS cells. Conversely, no obvious increases were observed
for A549 cells in any of the three sizes of AuNPs. The
authors eventually concluded that ROS signaling may play
a role in AuNP-induced apoptotic cell death in AGS cells.
Furthermore, western blot analyses revealed that the
expression of proteins involved in the anti-oxidative
defense system was not significantly modulated any of
the three sizes of AuNPs in both lines, except for a
modest increase in TrxR-1 and SOD-1 in AGS cells
[71]. Altogether, our results suggest that biologically
synthesized AuNPs have significant biocompatibility
and could possibly be used for ultrasensitive detection,
gene transfer, biomolecular imaging, drug delivery, and
cancer therapy.of DCF was measured using a spectrofluorometer with excitation at
D of three separate experiments, each of which contained three
different from the control group based on the Student's t test.
he control group based on the Student's t test (*p < 0.05).
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Synthesis of nanoparticles using biological systems is an
important area of nanobiotechnology. Here we show a
simple, rapid, clean, efficient, cost-effective, and green
method for the synthesis of biocompatible AuNPs using
Ganoderma spp. extract as a reducing and stabilizing
agent. The as-prepared AuNPs were characterized via
UV-vis, XRD, FTIR, EDX, DLS, and TEM. The biologic-
ally derived AuNPs were spherical, discrete, and the aver-
age size was 20 nm. The biocompatibility effect of AuNPs
was investigated using cell viability, LDH, and ROS assays.
The results indicate that biologically derived AuNPs are
biocompatible. Finally, this eco-friendly method provides
an alternative route for large-scale production of bio-
compatible AuNPs that can be used in catalysis, sensors,
electronics, and biomedical applications, especially for
cancer therapy.
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